Immunecare Biopharmaceuticals (shanghai) Co., Ltd.
Clinical trials sponsored by Immunecare Biopharmaceuticals (shanghai) Co., Ltd., explained in plain language.
-
New injection shows promise for Hard-to-Treat lung condition
Disease control Recruiting nowThis study tests an investigational drug called IMC-003 in 120 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work harder. Participants receive multiple injections of the drug or a placebo, alongside their usual treatments. The go…
Phase: PHASE1, PHASE2 • Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug aims to tame lupus flares
Disease control Recruiting nowThis study tests an experimental drug called IMC-002 (also known as IMM0306) in people with active systemic lupus erythematosus (SLE), a chronic autoimmune disease. The trial compares the drug against a placebo, both given alongside standard care, to see if it can reduce disease …
Phase: PHASE1, PHASE2 • Sponsor: ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC